Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
FDA, NIH pledge flexibility and $150M for animal alternatives
Draft guidance from the CDER invites applicants to provide data from animal testing alternatives even if they haven't been validated by the agency.
Darren Incorvaia
Mar 18, 2026 9:00am
Inovio trims team as trouble brews at FDA for rare disease drug
Mar 13, 2026 10:03am
CBER Director Vinay Prasad to depart FDA—again
Mar 6, 2026 5:30pm
Bavarian Nordic CEO exits after failed takeover—Chutes & Ladders
Mar 6, 2026 8:30am
Disc lays off 20% of workforce in wake of FDA rejection
Mar 3, 2026 10:45am
As CAR-T gains ground on solid tumors, red tape blocks progress
Feb 26, 2026 3:08pm
